Chloride channel agonist Amitiza (lubiprostone) had been shown to significantly relieve symptoms of Irritable Bowel Syndrome with Constipation (IBS-C).
Filed under: Ion Channel | Tagged: Sucampo, takeda, amitiza, CIC-2, CIC2, chloride channel, cl channel, lubiprostone, RU-0211, RU0211, SPI-0211, SPI0211 | Leave a Comment »
The FDA has approved Amitiza for the addtitional indication of irritable bowel syndrome with constipation (IBS-C) in women 18 years of age or older. It was previously launched in the US forchronic idiopathic constipation in 2006
Filed under: Ion Channel | Tagged: Sucampo, takeda, amitiza, CIC-2, CIC2, chloride channel, cl channel, lubiprostone, RU-0211, RU0211, SPI-0211, SPI0211 | Leave a Comment »
